← All trials
NCT01797718
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2013
- Primary completion
- Mar 20, 2017
- Completion date
- Apr 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 35
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of HelsinkiLead sponsor
- University of HelsinkiOverall official - principal investigator
- University of TurkuStudy chair
- Kuopio University HospitalStudy chair
- University of HelsinkiStudy director
- Government of FinlandStudy chair
- Foundation for Paediatric Research, FinlandCollaborator
- University of HelsinkiStudy chair
- University of HelsinkiReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.